![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
BioPharma
M&A Revival In The Biopharmaceutical Sector Back On Track
It is worth noting that the biopharmaceutical sector has gone on to experience a revival when it comes to mergers and acquisitions in the...
BioPharma
Biopharma & Healthcare In Asia-Pacific – Leveraging Ties
In the last five years, there have been various local governments in the Asia-Pacific region that have enacted beneficial policies and also regulatory frameworks...
BioPharma
CDMO-Biotech Collab Diminish Business Risk In Drug Creation
Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high...
BioPharma
Cryoport, CGT Catapult Partner on Cell and Gene Therapies
Cryoport, Inc. , a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of...
BioPharma
Biopharma Enhancing Visibility in Connected Supply Chain
The biopharmaceutical industry, with a market value exceeding $350 billion, stands as a cornerstone of global health innovation. The emergence of the Covid-19 pandemic...
BioPharma
Cell And Gene Therapy Market Soars, Forecasted At $82.24B
The global cell and gene therapy market has witnessed remarkable growth, with a market size of USD 15.46 billion in 2022. Projections indicate that...
BioPharma
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for medicines and new treatment options, it currently faces significant...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read